Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
131.00
-0.50 (-0.38%)
At close: Mar 27, 2026
TPEX:3218 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 779.24 | 506.85 | 1,063 | 703.02 | 534.19 |
Short-Term Investments | 90.56 | 115.22 | 578.36 | 576.62 | 505.81 |
Trading Asset Securities | 1,233 | 1,295 | - | - | - |
Cash & Short-Term Investments | 2,103 | 1,917 | 1,641 | 1,280 | 1,040 |
Cash Growth | 9.69% | 16.85% | 28.23% | 23.04% | -3.50% |
Accounts Receivable | 514.49 | 565.57 | 584.25 | 581.82 | 534.93 |
Other Receivables | 8.82 | 11.9 | 2.17 | 3.37 | 11.31 |
Receivables | 523.31 | 577.47 | 586.42 | 585.18 | 546.25 |
Inventory | 303.63 | 289.73 | 294.52 | 227.62 | 115.65 |
Other Current Assets | 71.1 | 57.19 | 58.03 | 66.54 | 77.21 |
Total Current Assets | 3,001 | 2,842 | 2,580 | 2,159 | 1,779 |
Property, Plant & Equipment | 2,823 | 2,673 | 2,323 | 2,206 | 1,724 |
Long-Term Investments | 108.74 | 111.07 | - | - | - |
Other Intangible Assets | 6.03 | 22.79 | 22.98 | 25.91 | 26.57 |
Long-Term Deferred Tax Assets | 73.79 | 72.26 | 67.25 | 55.91 | 48.31 |
Other Long-Term Assets | 79.87 | 41.34 | 137.06 | 59.25 | 171.76 |
Total Assets | 6,093 | 5,763 | 5,131 | 4,506 | 3,750 |
Accounts Payable | 224.37 | 268.07 | 312.31 | 254.55 | 210.5 |
Accrued Expenses | 217.42 | 226.34 | 226.54 | 210.26 | 170.08 |
Short-Term Debt | 93.49 | 92.01 | 8.67 | - | - |
Current Portion of Long-Term Debt | - | - | 1.3 | 9.17 | 9.03 |
Current Portion of Leases | 184.03 | 178.4 | 155.27 | 141.45 | 130.72 |
Current Income Taxes Payable | 146.25 | 154.45 | 162.57 | 134.37 | 85.7 |
Current Unearned Revenue | 36.43 | 25.12 | 24.19 | 23.32 | 16.24 |
Other Current Liabilities | 127 | 146.34 | 132.25 | 137.25 | 109.39 |
Total Current Liabilities | 1,029 | 1,091 | 1,023 | 910.38 | 731.66 |
Long-Term Debt | - | - | - | 1.32 | 10.33 |
Long-Term Leases | 785.82 | 783.83 | 613.02 | 631.7 | 617.45 |
Long-Term Deferred Tax Liabilities | 60.7 | 60.93 | 58.39 | 44.26 | 24.94 |
Other Long-Term Liabilities | 58.37 | 71.49 | 93.12 | 88.8 | 36.78 |
Total Liabilities | 1,934 | 2,007 | 1,788 | 1,676 | 1,421 |
Common Stock | 847.25 | 847.25 | 847.25 | 799.29 | 761.23 |
Additional Paid-In Capital | 381.92 | 381.92 | 381.92 | 381.92 | 381.92 |
Retained Earnings | 2,795 | 2,388 | 1,960 | 1,488 | 1,056 |
Comprehensive Income & Other | -1.19 | 4.51 | -11.38 | -5.04 | -10.37 |
Total Common Equity | 4,023 | 3,622 | 3,178 | 2,664 | 2,188 |
Minority Interest | 136.18 | 133.72 | 165.33 | 165.02 | 140.13 |
Shareholders' Equity | 4,159 | 3,756 | 3,343 | 2,829 | 2,328 |
Total Liabilities & Equity | 6,093 | 5,763 | 5,131 | 4,506 | 3,750 |
Total Debt | 1,063 | 1,054 | 778.26 | 783.65 | 767.53 |
Net Cash (Debt) | 1,040 | 863.2 | 862.65 | 495.99 | 272.47 |
Net Cash Growth | 20.47% | 0.07% | 73.92% | 82.03% | -41.23% |
Net Cash Per Share | 12.23 | 10.16 | 10.16 | 5.85 | 3.21 |
Filing Date Shares Outstanding | 84.72 | 84.73 | 84.73 | 84.72 | 84.72 |
Total Common Shares Outstanding | 84.72 | 84.73 | 84.73 | 84.72 | 84.72 |
Working Capital | 1,972 | 1,751 | 1,557 | 1,249 | 1,047 |
Book Value Per Share | 47.48 | 42.75 | 37.51 | 31.45 | 25.83 |
Tangible Book Value | 4,017 | 3,599 | 3,155 | 2,638 | 2,162 |
Tangible Book Value Per Share | 47.41 | 42.48 | 37.23 | 31.14 | 25.52 |
Land | 179.87 | 179.87 | 179.87 | 179.87 | 179.87 |
Buildings | 67.11 | 67.11 | 67.11 | 66.76 | 66.76 |
Machinery | 2,753 | 2,442 | 2,165 | 1,884 | 1,480 |
Construction In Progress | 69.92 | 96.01 | 32.82 | 91.84 | - |
Leasehold Improvements | 832.13 | 643.69 | 615.67 | 473.07 | 340.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.